NO20030533L - Vandige farmasöytiske preparater - Google Patents

Vandige farmasöytiske preparater

Info

Publication number
NO20030533L
NO20030533L NO20030533A NO20030533A NO20030533L NO 20030533 L NO20030533 L NO 20030533L NO 20030533 A NO20030533 A NO 20030533A NO 20030533 A NO20030533 A NO 20030533A NO 20030533 L NO20030533 L NO 20030533L
Authority
NO
Norway
Prior art keywords
aqueous pharmaceutical
pharmaceutical composition
administration
ofloxacin
antibacterial
Prior art date
Application number
NO20030533A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030533D0 (no
Inventor
Hidekazu Suzuki
Takahiro Wada
Masanobu Kirita
Masanobu Takeuchi
Original Assignee
Wakamoto Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakamoto Pharma Co Ltd filed Critical Wakamoto Pharma Co Ltd
Publication of NO20030533D0 publication Critical patent/NO20030533D0/no
Publication of NO20030533L publication Critical patent/NO20030533L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20030533A 2000-08-08 2003-02-03 Vandige farmasöytiske preparater NO20030533L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000240455A JP3450805B2 (ja) 2000-08-08 2000-08-08 水性医薬組成物
PCT/JP2001/006805 WO2002011734A1 (fr) 2000-08-08 2001-08-08 Compositions pharmaceutiques aqueuses

Publications (2)

Publication Number Publication Date
NO20030533D0 NO20030533D0 (no) 2003-02-03
NO20030533L true NO20030533L (no) 2003-02-26

Family

ID=18731808

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030533A NO20030533L (no) 2000-08-08 2003-02-03 Vandige farmasöytiske preparater

Country Status (13)

Country Link
US (2) US20030194441A1 (fr)
EP (1) EP1312366B1 (fr)
JP (1) JP3450805B2 (fr)
KR (1) KR20030040384A (fr)
CN (1) CN1446092A (fr)
AT (1) ATE376423T1 (fr)
AU (1) AU2001278696A1 (fr)
CA (1) CA2421787A1 (fr)
DE (1) DE60131088T2 (fr)
HU (1) HUP0302690A3 (fr)
NO (1) NO20030533L (fr)
RU (1) RU2003106395A (fr)
WO (1) WO2002011734A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003264498A1 (en) * 2002-09-18 2004-04-08 Wakamoto Pharmaceutical Co., Ltd. Transparent and reversibly heat-gelling aqueous compositions
US7220431B2 (en) 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
US20050085446A1 (en) * 2003-04-14 2005-04-21 Babu M.K. M. Fluoroquinolone formulations and methods of making and using the same
JP2005008625A (ja) * 2003-05-23 2005-01-13 Santen Pharmaceut Co Ltd キノロン系抗菌化合物を含有する点眼液
EP2404606A1 (fr) * 2003-08-21 2012-01-11 Sucampo AG Compositions ophtalmiques comprenant une prostaglandine et un agent de viscosité
JP4947977B2 (ja) * 2003-10-31 2012-06-06 わかもと製薬株式会社 可逆性熱ゲル化水性組成物
WO2005079809A1 (fr) * 2004-02-19 2005-09-01 Santen Pharmaceutical Co., Ltd. Gouttes pour les yeux transparentes au latanoprost
JP2005263792A (ja) * 2004-02-19 2005-09-29 Santen Pharmaceut Co Ltd 澄明なラタノプロスト点眼液
US7658947B2 (en) * 2004-06-25 2010-02-09 Kimberly-Clark Worldwide, Inc. Thermo-gelling composition
JP2007277095A (ja) * 2004-07-02 2007-10-25 Wakamoto Pharmaceut Co Ltd アジスロマイシン含有可逆性熱ゲル化水性組成物
JP2006036660A (ja) * 2004-07-23 2006-02-09 Wakamoto Pharmaceut Co Ltd 難溶性薬物含有水性懸濁熱ゲル製剤
US20060089384A1 (en) * 2004-10-25 2006-04-27 Minno George E Ophthalmic compositions and methods of using the same
DE602005020513D1 (de) * 2004-10-25 2010-05-20 Bausch & Lomb Ophthalmische zusammensetzungen und verfahren zu deren verwendung
US20080014274A1 (en) * 2006-07-14 2008-01-17 Wyeth Enhanced stability phenylephrine liquid compositions
CN101130083B (zh) * 2007-08-07 2010-05-19 山东博士伦福瑞达制药有限公司 一种眼用组合物及其制作方法和用途
ITMI20080289A1 (it) * 2008-02-22 2009-08-23 S I F I Societa Industria Farmaceutica Italia Composizioni di gemifloxacina con elevata efficacia su patologie oculari
EP2143422A1 (fr) * 2008-07-11 2010-01-13 S.I.F.I - Società Industria Farmaceutica Italiana - S.P.A. Compositions ophthalmiques contenant de la gémifloxacine pour le traitement d'infections oculaires
US7842725B2 (en) 2008-07-24 2010-11-30 Ecolab USA, Inc. Foaming alcohol compositions with selected dimethicone surfactants
TW201023912A (en) * 2008-12-05 2010-07-01 Alcon Res Ltd Pharmaceutical suspension
US8912236B2 (en) * 2009-03-03 2014-12-16 Alcon Research, Ltd. Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye
CN105362221A (zh) * 2009-03-03 2016-03-02 爱尔康研究有限公司 向眼部递送受体酪氨酸激酶抑制性(RTKi)化合物的药物组合物
DE102009021372A1 (de) * 2009-05-14 2010-11-18 Ursapharm Arzneimittel Gmbh Phosphatfreie pharmazeutische Zusammensetzung zur Glaukombehandlung
JP2013516485A (ja) * 2010-01-07 2013-05-13 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 耳にモキシフロキサシンを適用するための方法および組成物
CN101843625B (zh) * 2010-03-30 2012-02-08 重庆巴仕迪动物药业有限公司 兽用复方氧氟沙星注射液及其制备方法
MX2013000578A (es) * 2010-07-21 2013-02-21 Alcon Res Ltd Composicion farmaceutica con caracteristicas de solubilidad incrementadas.
US9937258B2 (en) * 2013-07-17 2018-04-10 Dow Global Technologies Llc Composition for application to a nasal mucosa comprising a methylcellulose
CN104000777B (zh) * 2014-05-21 2016-06-01 丽珠医药集团股份有限公司 一种左氧氟沙星制剂
CN104784101A (zh) * 2015-03-05 2015-07-22 中国药科大学制药有限公司 一种曲尼司特凝胶和软膏剂的处方及制备方法
EP3593806B1 (fr) 2017-04-25 2022-03-30 Wakamoto Pharmaceutical Co., Ltd. Larmes artificielles thermogélifiantes
US20180318319A1 (en) 2017-05-04 2018-11-08 Ocular Science, Inc. Compositions and Methods for Treating Eyes and Methods of Preparation
CN109260152A (zh) * 2018-11-13 2019-01-25 禹州市中医院 一种盐酸洛美沙星滴耳液
US11071724B2 (en) 2019-05-17 2021-07-27 Ocular Science, Inc. Compositions and methods for treating presbyopia
MX2022000928A (es) * 2019-07-23 2022-02-22 Nicox Ophthalmics Inc Proceso para la preparacion de suspensiones acuosas oftalmicas esteriles de nanocristales de la forma a de propionato de fluticasona.
CN117338787A (zh) * 2023-11-24 2024-01-05 南京恒道医药科技股份有限公司 一种眼用药物组合物及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2053678T3 (es) * 1987-11-13 1994-08-01 Asta Medica Ag Procedimiento para preparar un medicamento con contenido de azelastina para la aplicacion nasal y/u ocular.
DE69327878T2 (de) * 1993-04-16 2000-06-15 Wakamoto Pharma Co Ltd Unter wärmeeinwirkung reversibel gelierende medizinische zusammensetzung auf wasserbasis
EP0782850A4 (fr) * 1994-10-13 1998-03-04 Wakamoto Pharma Co Ltd Preparation lyophilisee permettant d'obtenir une composition pharmaceutique a base d'eau se transformant de maniere reversible en gel sous l'effet de la chaleur
CA2210749C (fr) * 1995-01-20 2001-04-10 Wakamoto Pharmaceutical Co., Ltd. Gouttes oculaires anti-inflammatoires
ZA966579B (en) * 1995-08-04 1998-02-02 Wakamoto Pharma Co Ltd O/W emulsion composition for eye drops.
WO1998030221A1 (fr) * 1997-01-10 1998-07-16 Wakamoto Pharmaceutical Co., Ltd. Composition de type emulsion huile/eau a usage ophtalmique et contenant du difluprednate
WO1999016471A1 (fr) * 1997-10-01 1999-04-08 Wakamoto Pharmaceutical Co., Ltd. Compositions d'emulsions de type aqueux
US6171616B1 (en) * 1998-04-13 2001-01-09 Shin-Etsu Chemical Co., Ltd. Solid preparation and a method of manufacturing it
WO1999059634A1 (fr) * 1998-05-15 1999-11-25 Wakamoto Pharmaceutical Co., Ltd. Gouttes oculaires anti-inflammatoires
AU4061599A (en) * 1998-06-10 1999-12-30 Wakamoto Pharmaceutical Co., Ltd. Aqueous preparations containing hardly soluble drug
JP2001048807A (ja) * 1999-08-04 2001-02-20 Wakamoto Pharmaceut Co Ltd 難溶性薬物を水に溶解してなる製剤
WO2001037838A1 (fr) * 1999-11-24 2001-05-31 Wakamoto Pharmaceutical Co., Ltd. Preparation aqueuse ophtalmique
JP4541504B2 (ja) * 2000-06-14 2010-09-08 沢井製薬株式会社 トラニラストまたはその薬理学的に許容される塩を有効成分として含有する安定な水溶液製剤
JP2002097129A (ja) * 2000-07-21 2002-04-02 Rohto Pharmaceut Co Ltd 点眼剤

Also Published As

Publication number Publication date
ATE376423T1 (de) 2007-11-15
EP1312366A1 (fr) 2003-05-21
EP1312366A4 (fr) 2006-04-26
KR20030040384A (ko) 2003-05-22
CA2421787A1 (fr) 2003-02-04
HUP0302690A2 (hu) 2003-11-28
EP1312366B1 (fr) 2007-10-24
CN1446092A (zh) 2003-10-01
HUP0302690A3 (en) 2004-06-28
JP3450805B2 (ja) 2003-09-29
US20060172969A1 (en) 2006-08-03
AU2001278696A1 (en) 2002-02-18
EP1312366A8 (fr) 2003-11-12
WO2002011734A1 (fr) 2002-02-14
US20030194441A1 (en) 2003-10-16
DE60131088T2 (de) 2008-07-31
NO20030533D0 (no) 2003-02-03
RU2003106395A (ru) 2004-07-27
DE60131088D1 (de) 2007-12-06
US7612115B2 (en) 2009-11-03
JP2003160473A (ja) 2003-06-03

Similar Documents

Publication Publication Date Title
NO20030533L (no) Vandige farmasöytiske preparater
HRP20020880B1 (en) New pharmaceutical composition
MY129350A (en) Aripiprazole oral solution
UY27320A1 (es) Nuevas composiciones farmacéuticas
WO2002019969A3 (fr) Acide (5-(2-hydroxy-4-chlorobenzoyl) aminovalerique et ses sels, compositions contenant l'acide et ses sels pour acheminer des agents actifs
BRPI0411678A (pt) nanopartìculas de ácido hialurÈnico
ATE275393T1 (de) Feste dispersionen mit nitrataktiven wirkstoffen
NO20010863D0 (no) Nye orale formuleringer for 5-HT4-agonister eller - antagonister
HRP20020298B1 (en) Pharmaceutical solutions of levosimendan
DE69224071T2 (de) Chinolan-antibiotika und polystyrolsulfonat enthaltende zusammensetzungen
ATE420638T1 (de) Stabile feste medizinische zusammensetzung für die orale verabreichung von ramosetron
DK1228758T3 (da) Anvendelse af sulfodehydroabietinsyre til behandling af inflammatorisk tarmsygdom
ID22668A (id) Bahan bentuk jelli nimesulida untuk dipakai di tempat sakit
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
FR2804286B1 (fr) Utilisation de derives de polyaminoacides comme agents conservateurs, compositions les comprenant et procede de conservation les utilisant
SE0002476D0 (sv) New compounds
ATE308537T1 (de) Neue 1-amidomethylcarbonyl-piperidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ATE324103T1 (de) Arzneizubereitung mit kontrollierter freisetzung enthaltend tramadol hydrochlorid
SE0001916D0 (sv) Novel formulation
CA3188980A1 (fr) Compositions de phytonadione
DE60003074D1 (de) Fusidinsäure-derivate
TR200103212T2 (tr) Mantar ilacı olarak kullanılan eterler
WO2001003774A3 (fr) Composition pharmaceutique de traitement de la calcification
DE60104530D1 (de) Diphenyl ketoaldehyde-derivate mit wirkung gegen hiv
JP2005247801A (ja) 安定な点眼剤

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application